Rosomni-Gold 75/75/10 vs 75/75/20 and Other Variants

EMK Omni Pharma markets several related cardiac care products, and the names can look similar on a prescription. The differences are worth knowing.

Read the strip carefully when you collect your medicine, because the brand family is shared but the contents are not.

These two are closest to each other. Both contain Aspirin 75 mg and Clopidogrel 75 mg, so the antiplatelet cover is the same. The only difference is the statin strength: 10 mg of rosuvastatin in one and 20 mg in the other.

A doctor may choose the 20 mg version when LDL cholesterol needs to come down further than the 10 mg strength has managed, or when the risk profile calls for more intensive lipid lowering from the start. The 10 mg strength may be preferred when the target is closer, when a patient is older or lighter, when kidney function is reduced, or when a higher statin dose has caused muscle complaints in the past.

Moving between the two is a clinical decision, usually made after reviewing a fresh lipid profile.

Rosomni-A 75/10 contains Aspirin 75 mg and Rosuvastatin 10 mg. Compared with Rosomni-Gold 75/75/10, the clopidogrel is absent.

That single difference changes the clinical setting. Dual antiplatelet therapy is generally reserved for situations where a doctor judges that two platelet pathways need covering, such as a defined period after a coronary stent or an acute coronary event. Once that period is complete, a doctor may step down to a single antiplatelet with a statin, which is where Rosomni-A 75/10 fits.

More antiplatelet cover is not automatically better, since each additional agent adds bleeding risk.

Rosomni-10 is Rosuvastatin Tablets IP 10 mg, with no aspirin and no clopidogrel. It addresses cholesterol only.

This suits people who need lipid lowering but for whom a doctor has decided antiplatelet therapy is not appropriate, perhaps because they have no established coronary disease, or because bleeding risk is a concern. It is also the form used when a doctor wants to control the statin dose separately from any antiplatelet plan.

Note the form difference too. Rosomni-10 is a tablet, while the Gold products and Rosomni-A are capsules that must be swallowed whole because of the enteric-coated aspirin pellets inside.

The choice usually turns on a handful of questions. What is the current LDL cholesterol and target? Is there established coronary disease, a recent stent or an acute event? How long has dual antiplatelet therapy already run? What is the bleeding risk, including any ulcer history? How are the kidneys and liver?

Because those answers change, the prescription can change as well. That is normal and does not mean the earlier choice was wrong.

It can be tempting to accept a nearby strength when a chemist is out of stock, or to continue an old strip found at home. Please do not.

Doubling the statin strength without review can increase the chance of muscle and liver effects. Dropping clopidogrel on your own after a stent removes cover that your cardiologist deliberately planned. Adding it back without advice raises bleeding risk instead.

If your usual product is unavailable, ask the chemist to source it, or contact your doctor for a written alternative. Pharmacies and distributors can also check supply of Rosomni-Gold 75/75/10 with EMK Omni Pharma directly.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.